Prelude Therapeutics
PRLD
PRLD
49 hedge funds and large institutions have $22M invested in Prelude Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-9
Holders Change %
-15.52%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
23
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CF
Cantor Fitzgerald
New York
|
+$171K |
| 2 |
Millennium Management
New York
|
+$82.3K |
| 3 |
Jane Street
New York
|
+$74.3K |
| 4 |
SC
Shay Capital
New York
|
+$60.7K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$58K |
Top Sellers
| 1 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
-$3.62M |
| 2 |
BCM
Boxer Capital Management
San Diego,
California
|
-$1.62M |
| 3 |
BlackRock
New York
|
-$498K |
| 4 |
State Street
Boston,
Massachusetts
|
-$153K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$152K |
